Prior exposure to coronaviruses that cause ordinary colds can boost the immune system's ability to attack a vulnerable site ...

The bat harbored the BRZ batCoV virus, which the researchers say has likely been silently circulating in Latin America for ...

Increased risk of DENV-infection (primarily DENV3) was observed up to 300 days post-SARS-CoV-2 infection (predominantly ...

Since the start of the COVID-19 pandemic, there has been controversy surrounding the origins of SARS-CoV-2. New research from the University of California, San Diego (UCSD), School of Medicine ...

Maternal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with an increased risk for ...

Background Immunogenicity to SARS-CoV-2 vaccination in patients with SLE varies by vaccine type and immune-modulating therapy. However, data in Southeast Asian populations, especially among Thai ...

By 30 September 2025, SARS reported a net revenue collection of R924.7 billion, surpassing expectations and marking another milestone in the agency’s modernization and compliance-driven strategy.

The global pandemic may be over, but SARS-CoV-2 continues to infect people around the world. Indeed, the United States has recorded roughly 750 deaths from COVID-19 over the past month. Now, an siRNA ...

Research reveals a sharp decline in both the effectiveness and duration of protection from prior infection post-Omicron, underscoring the need for updated vaccines to sustain immunity Study: ...

A new study reveals women are three times more likely to experience severe long COVID due to biological differences.